The development of PARP as a successful target for cancer therapy
Author:
Affiliation:
1. Section of Oncology, Department of Medicine, Università degli Studi di Verona, Verona, Italy
2. Medical Oncology Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy
3. Medical Oncology Department, Gustave Roussy, Villejuif, France
Funder
Associazione Italiana per la Ricerca sul Cancro
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Oncology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14737140.2018.1419870
Reference155 articles.
1. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
2. Genome maintenance mechanisms for preventing cancer
3. Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells
4. Classical and Alternative End-Joining Pathways for Repair of Lymphocyte-Specific and General DNA Double-Strand Breaks
5. The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Major adverse cardiac events and cardiovascular toxicity with PARP inhibitors-based therapy for solid tumors: a systematic review and safety meta-analysis;ESMO Open;2023-04
2. In Silico Investigation of the Molecular Mechanism of PARP1 Inhibition for the Treatment of BRCA-Deficient Cancers;Molecules;2023-02-15
3. Replication Stress: A Review of Novel Targets to Enhance Radiosensitivity-From Bench to Clinic;Frontiers in Oncology;2022-07-08
4. Target based chemotherapeutic advancement of ruthenium complexes;Coordination Chemistry Reviews;2021-12
5. Computational investigation of FDA approved drugs as selective PARP-1 inhibitors by targeting BRCT domain for cancer therapy;Journal of Molecular Graphics and Modelling;2021-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3